BASELINE IL-23 SERUM LEVELS PREDICT THERAPEUTIC RESPONSE TO USTEKINUMAB THERAPY IN CROHN'S DISEASE. A PROSPECTIVE STUDY

Lorenzo Bertani  1     Luca Antonioli  1     Marco Fornili  1     Vanessa D'Antongiovanni  1     Francesca Coppini  1     Ceccarelli Linda  2     Laura Benvenuti  2     Maria Gloria Mumolo  2     Laura Baglietto  2     Massimo Bellini  2     Matteo Fornai  2     Nicola de Bortoli  2     Francesco Costa  2    
1 University of Pisa, Pisa, Italy
2 Pisa University Hospital, Pisa, Italy

Session
Response prediction in IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing